Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

2(28.6%)

Early Phase 1

1(14.3%)

7Total

N/A(4)

Phase 4(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05680805Phase 4Active Not Recruiting

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

Role: collaborator

NCT06547606Not ApplicableNot Yet Recruiting

Effect of Resistive Inspiratory Muscle Training Optimizing Lung Function in Spinal Cord Injury

Role: lead

NCT06340542Not ApplicableCompleted

Comparison of Thoracic Mobility Exercise Versus Manual Release Technique in Minimizing Upper Back Pain

Role: lead

NCT06277843Early Phase 1Completed

Low-Cost and Reusable Thermal Jacket for Managing Preterm or Low Birth Weight Neonates.

Role: collaborator

NCT02746003Not ApplicableUnknown

Health Impacts of a Climate Change Adaptation Strategy to Address Drinking-water Salinity in Coastal Bangladesh

Role: collaborator

NCT03321591Unknown

Maternal Cognitive Function and Neurobehavioral Development of Underprivileged Children

Role: lead

NCT02731547Not ApplicableUnknown

Education Against Tobacco Randomized Trial in Bosnia and Herzegovina

Role: collaborator

NCT01589445Phase 4Completed

Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects

Role: lead

All 8 trials loaded